MedPath

The effect of ginger-quince compound on nausea and vomiting induced by chemotherapy and radiotherapy

Phase 3
Conditions
ausea and vomiting.
Nausea and vomiting
Registration Number
IRCT2012113011615N1
Lead Sponsor
Research vice-chancellor, Tehran university of medical sciences and health services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
240
Inclusion Criteria

Suffering from cancer; definitely diagnosed by a pathologist; 18?? year-old or more; under chemotherapy treatments; simultaneous radiotherapy treatments inducing ?nausea and vomiting such as whole body or upper abdomen RT.
Exclusion criteria: Warfarin and Heparin ?treatment; ASA consuming more than 80 mg; history of? blood disorders; history of severe thrombocytopenia; allergy to ginger or consuming it during the ?past week; gastro-intestinal cancers; having nausea and vomiting induced by factors except ?chemotherapy or radiotherapy such as CNS tumors, HTN, renal failure or hepatic disorders; gastrointestinal ?problems like gastric or peptic ulcers; forgetting the use of capsules three consecutive times or more.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea severity. Timepoint: During the intervention, weekly. Method of measurement: Visual analogue scale.;Number of vomiting. Timepoint: During the intervention, weekly. Method of measurement: Data registration form.;Duration of vomiting. Timepoint: During the intervention, weekly. Method of measurement: Data registration form.;Duratin of nausea. Timepoint: During the intervention, weekly. Method of measurement: Data registration form.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath